Results 211 to 220 of about 11,622 (298)

Ethical and Legal Implications of Implementing AI in Gastrointestinal Endoscopy

Digestive Endoscopy, Volume 38, Issue 6, June 2026.
ABSTRACT Artificial intelligence (AI) is advancing rapidly in gastrointestinal endoscopy, offering new opportunities to enhance diagnostic accuracy, procedure quality, and clinical efficiency. However, its integration into practice raises a range of complex challenges.
Ahmed El‐Sayed, Syed Geelani, Sherif El‐Sayed, Hassan Ali Choudry, Laurence B. Lovat, Omer F. Ahmad   +5 more
wiley   +1 more source

Comparison of the Efficacy of Different Traditional Chinese Exercises in the Treatment of Chronic Non-Specific Low Back Pain: A Bayesian Network Meta-Analysis. [PDF]

J Pain Res
Huang M, Liu H, Zeng L, Chen J.
europepmc   +1 more source

Mental Health Study from the Perspective of Behavior Preference under the Environment of Internet Media: Based on China's Data Analysis.

J Environ Public Health, 2022
Chen G, Zhong Y, Yu W, Yan J.
europepmc   +1 more source

On Schopenhauer's Debt to Spinoza1

European Journal of Philosophy, Volume 34, Issue 2, Page 656-672, June 2026.
Abstract Schopenhauer offers ‘nature is not divine but demonic’ as a direct rebuttal of Spinoza's pantheism, his identification of ‘nature’ with ‘God’. And so, one would think, he ought to have been immune to the ‘Spinozism’ that became, as Heine called it, ‘the unofficial religion’ of the age.
Julian Young
wiley   +1 more source

The benefits of leisure activities on healthy life expectancy for older people with diabetes. [PDF]

Diabetol Metab Syndr
Huang IW, Weng SJ, Liao CH, Xu YY, Hsieh LP, Liu SC, Tsai YT.   +6 more
europepmc   +1 more source

Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4‐Year CASTING–LIBERTO Trial

European Journal of Neurology, Volume 33, Issue 6, June 2026.
ABSTRACT Background Almost 75% of patients with relapsing multiple sclerosis (pwRMS) with suboptimal response to other disease‐modifying therapies (DMTs) showed no evidence of disease activity (NEDA‐3) when treated with ocrelizumab in a large single‐arm multicentre trial over 2 years.
Patrick Vermersch, Ralph H. B. Benedict, Bart Van Wijmeersch, Gary Cutter, llya Kister, Celia Oreja‐Guevara, Aksel Siva, Heinz Wiendl, Jens Wuerfel, Bouchra El Azzouzi, Thomas Kuenzel, Regine Buffels, Licinio Craveiro, Petra Dirks, Giancarlo Comi   +14 more
wiley   +1 more source

Cataloguing and theorising open research practices in the arts, humanities and social sciences: Problematising and diversifying 'Open Science'. [PDF]

F1000Res
Adams J, Barnes M, Moore S, Pinfield S.
europepmc   +1 more source

Las voces de Baha‐blantes: An analysis of the language learning investment of intermediate students of Spanish at the tertiary level

Foreign Language Annals, Volume 59, Issue 2, Page 337-357, Summer 2026.
Abstract This study examines the language learning investment of five intermediate learners of Spanish at a tertiary institution in The Bahamas. It draws on participants’ language learning journeys to consider how their previous experiences and access to language learning opportunities contributed to their investment.
Valentino Rahming
wiley   +1 more source

Barriers and Strategies to Access HIV Prevention and Care Services among the Latino/a Community in Colorado. [PDF]

J Racial Ethn Health Disparities
Iriarte E, Uribe-Joyner G, Burk-Leaver E, Stonbraker S, Jankowski C, Amura CR, Carrillo-Chavez S, Barrientos Ortiz C, Erlandson KM.   +8 more
europepmc   +1 more source

Real‐world use of second‐generation integrase strand transfer inhibitors (INSTI) as switch therapy in the prospective ANRS‐CO3‐AquiVIH‐NA cohort

HIV Medicine, Volume 27, Issue 6, Page 965-978, June 2026.
Abstract Objectives To characterize real‐world treatment switching in France to bictegravir (BIC or B) or dolutegravir (DTG)‐based regimens with a focus on treatment persistence, effectiveness (HIV‐1 RNA ≤50 copies/ml) and particular attention to the prevalence and incidence of comorbidities. Methods People living with HIV from the prospective ANRS‐CO3‐
O. Leleux, A. Peyrouny‐Mazeau, A. Perrier, M. Hessamfar, G. Le Moal, D. Neau, L. Alleman, C. Cazanave, E. Lazaro, P. Duffau, A. Riché, Y. Gérard, G. Barrière, S. Reigadas, M.‐A. Vandenhende, F. Bonnet   +15 more
wiley   +1 more source